These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31281314)

  • 1. SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.
    Sangaletti S; Talarico G; Chiodoni C; Cappetti B; Botti L; Portararo P; Gulino A; Consonni FM; Sica A; Randon G; Di Nicola M; Tripodo C; Colombo MP
    Front Immunol; 2019; 10():1369. PubMed ID: 31281314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
    Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP
    Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs.
    Porta C; Consonni FM; Morlacchi S; Sangaletti S; Bleve A; Totaro MG; Larghi P; Rimoldi M; Tripodo C; Strauss L; Banfi S; Storto M; Pressiani T; Rimassa L; Tartari S; Ippolito A; Doni A; Soldà G; Duga S; Piccolo V; Ostuni R; Natoli G; Bronte V; Balzac F; Turco E; Hirsch E; Colombo MP; Sica A
    Cancer Res; 2020 Jul; 80(13):2874-2888. PubMed ID: 32265223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3.
    Ma M; Huang W; Kong D
    Int Immunopharmacol; 2018 Jun; 59():148-156. PubMed ID: 29655056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice.
    Ma Z; Zhen Y; Hu C; Yi H
    Front Immunol; 2020; 11():687. PubMed ID: 32391010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
    Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I
    Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
    Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
    J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.
    Köstlin N; Vogelmann M; Spring B; Schwarz J; Feucht J; Härtel C; Orlikowsky TW; Poets CF; Gille C
    Immunology; 2017 Sep; 152(1):89-101. PubMed ID: 28464218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.
    Obermajer N; Wong JL; Edwards RP; Odunsi K; Moysich K; Kalinski P
    Immunol Invest; 2012; 41(6-7):635-57. PubMed ID: 23017139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NF-κB1/p50 Subunit Influences the Notch/IL-6-Driven Expansion of Myeloid-Derived Suppressor Cells in Murine T-Cell Acute Lymphoblastic Leukemia.
    Abdollahzadeh B; Cantale Aeo NM; Giordano N; Orlando A; Basciani M; Peruzzi G; Grazioli P; Screpanti I; Felli MP; Campese AF
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1α, 25 Dihydroxyvitamin D (1,25(OH)
    Fleet JC; Burcham GN; Calvert RD; Elzey BD; Ratliff TL
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105557. PubMed ID: 31783150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
    Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
    J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
    Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
    Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.
    Sinha P; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic screen in myeloid cells identifies TNF-α autocrine secretion as a factor increasing MDSC suppressive activity via Nos2 up-regulation.
    Schröder M; Krötschel M; Conrad L; Naumann SK; Bachran C; Rolfe A; Umansky V; Helming L; Swee LK
    Sci Rep; 2018 Sep; 8(1):13399. PubMed ID: 30194424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
    Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
    Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
    [No Abstract]   [Full Text] [Related]  

  • 18. Matricellular proteins tune myeloid-derived suppressor cell recruitment and function in breast cancer.
    Chiodoni C; Sangaletti S; Colombo MP
    J Leukoc Biol; 2017 Aug; 102(2):287-292. PubMed ID: 28148719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
    Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.
    Haverkamp JM; Crist SA; Elzey BD; Cimen C; Ratliff TL
    Eur J Immunol; 2011 Mar; 41(3):749-59. PubMed ID: 21287554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.